Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 28, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Post-irradiation cutaneous angiosarcoma.

Rohtesh S Mehta1, Michael Mikhail

  • 1Resident (PGY-3), Department of Internal Medicine, Mercy Catholic Medical Center/Drexel University School of Medicine, Mercy Fitzgerald Hospital, 1500 Lansdowne Avenue, Medical Science Building, Darby, PA, 19023, USA. rohtesh@yahoo.com.

Cases Journal
|October 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.

Bone marrow transplantation·2026
Same author

Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS.

Transplantation and cellular therapy·2026
Same author

HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

Bone marrow transplantation·2026
Same author

Absolute Risk Trade-offs of Donor Age, Sex, and Graft Source in PTCy-Based Transplantation.

Blood advances·2026
Same author

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

American journal of hematology·2026
Same author

Uncoupling toxicity from efficacy in donor selection for allogeneic hematopoietic cell transplantation: a retrospective cohort study using double machine learning.

Journal of hematology & oncology·2026
Same journal

Upper gastrointestinal bleeding due to gastric stromal tumour: a case report.

Cases journal·2010
Same journal

Interstitial lung disease associated to erlotinib treatment: a case report.

Cases journal·2010
Same journal

Repair of a defect following the removal of an impacted maxillary canine by orthodontic tooth movement: a case report.

Cases journal·2010
Same journal

Dihydrotachysterol intoxication treated with pamidronate: a case report.

Cases journal·2010
Same journal

Posttraumatic proliferating trichilemmal tumour on the frontal region of the scalp: a case report.

Cases journal·2010
Same journal

Acute Subarachnoid Hemorrhage and Cardiac Abnormalities: Takotsubo Cardiomyopathy or Neurogenic Stunned Myocardium? a case report.

Cases journal·2010
See all related articles

Cutaneous angiosarcoma is a rare, aggressive cancer that can recur after treatment. This case highlights a patient with breast cancer experiencing repetitive tumor regrowth, ultimately leading to a poor outcome.

Area of Science:

  • Oncology
  • Surgical Pathology

Background:

  • Angiosarcoma is a rare, aggressive vascular tumor.
  • It has a high propensity for recurrence and metastasis.
  • Previous radiation therapy and lymphedema are known risk factors.

Purpose of the Study:

  • To report a rare case of cutaneous angiosarcoma.
  • To discuss its occurrence at a lumpectomy site following breast cancer treatment.
  • To emphasize the challenges in managing recurrent angiosarcoma.

Main Methods:

  • Case presentation and clinical history review.
  • Histopathological examination of the tumor.
  • Review of treatment modalities and patient outcomes.

Main Results:

Related Experiment Videos

Last Updated: Jun 28, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

  • A patient with a history of breast cancer developed cutaneous angiosarcoma at the lumpectomy site.
  • The angiosarcoma demonstrated aggressive behavior with repetitive recurrence.
  • Despite multiple treatments, the disease progressed, leading to patient mortality.

Conclusions:

  • Cutaneous angiosarcoma is a challenging diagnosis with a poor prognosis.
  • Recurrence at prior radiation or surgical sites is a significant concern.
  • Multidisciplinary management and further research are needed for improved outcomes.